Skip to main content
. 2022 Jan 10;2022:4180215. doi: 10.1155/2022/4180215

Figure 1.

Figure 1

List of most important microRNAs (miRNAs) involved in venous thromboembolism. Deep venous thrombosis (DVT) determinants are classically grouped into the Virchow trial. They may be influenced by a wide range of miRNAs, especially hypercoagulability and endothelial dysfunction. Less is known about pulmonary embolism (PE). Whereas pathophysiological data are still lacking, different miRNAs are being increasingly described as potential biomarker of disease.